Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc > What's up with ASCO?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(258)
•••
Comment by qwerty22on May 14, 2020 4:05pm
97 Views
Post# 31029502

RE:RE:RE:RE:What's up with ASCO?

RE:RE:RE:RE:What's up with ASCO?

I just can't remember what the basket trial schedule was.
This PR from earlier this year suggests that it was just this Ovarian poster that was submitted to ASCO. You sure you're remembering right.

https://stockhouse.com/news/press-releases/2020/02/04/clinical-translational-data-supporting-dpx-survivac-mechanism-of-action-to-be


Breakthorough1 wrote: Before February 11th: https://asco.confex.com/asco/2020/cfp.cgi

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities